Physician profile
Joanne E Chekansky
NPI 1780605626
$561.06
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.47 · 2022: $187 · 2023: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $185.07 | 2022-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $68.17 | 2022-2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.96 | 2023 | Tradjenta, Synjardy, Jardiance |
| Astellas Pharma US INC | $47.55 | 2021-2023 | Veozah |
| Astrazeneca Pharmaceuticals LP | $30.64 | 2022-2023 | Farxiga |
| Abbvie INC. | $19.47 | 2023 | |
| Paratek Pharmaceuticals, INC. | $19.40 | 2022 | |
| Mannkind Corporation | $18.60 | 2023 | Afrezza |
| Janssen Pharmaceuticals, INC | $18.20 | 2023 | Xarelto |
| Exact Sciences Corporation | $16.24 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $16.04 | 2022 | |
| Glaxosmithkline, LLC. | $15.17 | 2023 | Arexvy |
| Merck Sharp & Dohme LLC | $15.11 | 2022 | |
| Medtronic, INC. | $14.67 | 2023 | Clydesdale Ptc Spinal System |
| Amgen INC. | $12.77 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joanne Chekansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.